Skip to main content
OpenTrials
Completed

NCT Number: NCT05810493

A Cohort of Patients With Phenotyped Diffuse Interstitial Lung Disease With Longitudinal Follow-up

The purpose of the study is to conduct a descriptive analysis of the population of patients with an interstitial lung disease received in the pulmonary department of University hospital of Nice (France). Analysis and documentation of clinical forms of the disease, therapeutics used and evolutions.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

University Hospital of Nice

Nice, 06200, France

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Age ≥ 18 years old
  • Diagnosis of interstitial lung disease according to the multidisciplinary monthly meeting for interstitial lung disease occuring at University hospital of Nice, France

Exclusion criteria

  • Patient-led opposition to data collection

Treatment and study plan

observation

Other

Follow-up of disease, therapeutics and evolution

Primary outcomes

  1. Build a retrospective cohort of patients with phenotyped interstitial Lung disease with longitudinal follow-up

    Time frame: 2 years

Secondary outcomes

  1. Follow-up of progression criteria according to diagnosis

    Time frame: 2 years

    Change in pulmonary functional tests

  2. Follow-up of progression criteria according to diagnosis

    Time frame: 2 years

    Change in respiratory symptoms

  3. Follow-up of progression criteria according to diagnosis

    Time frame: 2 years

    Change in High-resolution Computed Tomography (HRCT) images

  4. Follow-up of progression criteria according to diagnosis

    Time frame: 2 years

    Impact of interstitial lung disease treatements

Sponsors and collaborators

Lead sponsor

Centre Hospitalier Universitaire de Nice

Other

Registry information

Important dates

Study start
2022
Primary completion
2022
Study completion
2023
First posted
Apr 12, 2023
Registry last updated
Jun 29, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.